Migraine with and without aura in the same patient: Expression of a single clinical entity?

Cephalalgia

Volumn 17, Issue 5, 1997, Pages 585-587

  Centonze, V ^a,b   Polito, B M ^a   Valerio, A ^a   Cassiano, M A ^a   Amato, R ^a   Ricchetti, G ^a   Bassi, A ^a   Valente, A ^a   Albano, O ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NONE   (Italy)

Author keywords

Clinical evaluation; Migraine with aura; Migraine without aura

Indexed keywords

5 HYDROXYTRYPTOPHAN; DIHYDROERGOTAMINE; FLUNARIZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; EPILEPTIC AURA; FEMALE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIGRAINE; SYMPTOMATOLOGY; THEORY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUESTIONNAIRES;

EID: 0030860193     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1705585.x     Document Type: Article

References (13)

1. Wilkinson M. Clinical features of migraine. In: Clifford Rose, editor. Handbook of clinicl neurology, vol. 4:Headache. Amsterdam: Elsevier Science Publishers, 1986:117-33
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
3. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatritan. N Engl J Med 1991;325:316-21
4. Anderson PG, Dahl S, Hansen PE, Hedman PE, Hedman C, Kristensen TN, de Olivarius F. Prophylactic treatment of classical and non-classical migraine with metoprolol. A comparison with placebo. Cephalalgia 1983;3:207-12
5. Centonze V, Magrone D, Vino M, Caporaletti P, Attolini E, Campanale G, Albano O. Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia 1990;10:17-24
6. Gawel M. A double-blind, cross-over study of nimodipine versus pizotyline in common and classical migraine. Cephalalgia 1987;7 Suppl 6:453-4
7. Bussone G, Frediani F, Lamperti L, Boiardi A. 5-HTP in migraine headache treatment: actual views and perspectives. Cephalalgia 1987;7 Suppl 6:514-6
8. Dalessio DJ. Is there a difference between classic and common migraine? What is migraine after all? Arch Neurol 1985;42: 275-6
9. Couch JR, Bearss C, Laswell K. Lack of differentiation between classic and common migraine by clinical symptomatology. Thirty-first Annual Scientific Meeting of the American Association for the Study of Headache, 16-18 June, Boston, MA Platform papers. Headache 1989;29:311
10. Lagreze HL, Dettmers C, Hartmann [?INITIAL]. Abnormalities of interictal cerebral perfusion in classic but not common migrine. Stroke ?VOL. NO.;18:1108-11
11. Olesen J, Larsen B, Lauritzen M. Focal hyperaemia followed by spreading oligaemia and impaired activation of regional cerebral blood flow in classic migraine. Ann Neurol 1981;9: 344-52
12. Olesen J, Tfelt-Hansen P, Henriksen L, Larsen B. The common migraine attack may not be initiated by cerebral ischaemia. Lancet 1981;ii:438-40
13. Lauritzen M, Olsen TS, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983;13:633-41